|
Nov 13
|
Late-Breaking Data Show an Aspirin-Free Medication Regimen Benefits People with Abbott's HeartMate 3™ Heart Pump
|
|
Nov 12
|
Investing in Abbott Laboratories (NYSE:ABT) five years ago would have delivered you a 42% gain
|
|
Nov 10
|
Hologic's (HOLX) Q4 Earnings Beat Estimates, Gross Margin Down
|
|
Nov 9
|
BD (BDX) Q4 Earnings In-Line With Estimates, Margins Contract
|
|
Nov 9
|
Here's Why You Should Retain Boston Scientific (BSX) Now
|
|
Nov 9
|
Alcon (ALC) Unveils New Progress in Presbyopia Correcting IOLs
|
|
Nov 9
|
Surmodics (SRDX) Q4 Earnings Top Estimates, Revenues Up Y/Y
|
|
Nov 9
|
Inspire Medical (INSP) Q3 Earnings Top Estimates, Revenues Lag
|
|
Nov 9
|
2 No-Brainer Stocks to Buy for Forever Dividend Growth
|
|
Nov 9
|
11 Best S&P 500 Stocks To Buy According to Ray Dalio’s Bridgewater Associates
|
|
Nov 9
|
Top 20 Drug Companies in the US by Revenue
|
|
Nov 8
|
Participants in Abbott's Food as Medicine Program Showed Clinically Significant Improvements in Managing Diabetes
|
|
Nov 8
|
Inogen (INGN) Q3 Earnings Miss Estimates, Revenues Down Y/Y
|
|
Nov 8
|
Accuray (ARAY) Q1 Earnings In-Line With Estimates, Revenues Top
|
|
Nov 8
|
Charles River's (CRL) Q3 Earnings Beat, Margins Decline
|
|
Nov 8
|
DaVita (DVA) Q3 Earnings & Revenues Top Estimates, Margins Up
|
|
Nov 8
|
2 Medical Device Companies Experiencing Strong Demand Even as Weight-Loss Drugs Rise in Popularity
|
|
Nov 8
|
Masimo (MASI) Q3 Earnings Beat Estimates, Margins Fall
|
|
Nov 8
|
Globus Medical (GMED) Q3 Earnings Top Estimates, Margins Down
|
|
Nov 8
|
Here's Why You Should Retain Align Technology (ALGN) Stock Now
|